Regulation And Legal
CDSCO Approves India's First Dengue Vaccine Qdenga
CDSCO granted marketing authorization for India's first dengue vaccine Qdenga® manufactured by Takeda GmbH for ages 4-60 years.
The recombinant live attenuated tetravalent vaccine requires two doses a
